Showing results (561-570 of 638) with videos related to

Sort By:
Pageof 64
Nature Communications|June 21, 2017
Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor 2,4-dihydroxybutyric acidThomas Walther, Christopher M Topham, Romain Irague, et al.
JACC. Cardiovascular Interventions|November 20, 2020
Transcatheter Versus Rapid-Deployment Aortic Valve Replacement: A Propensity-Matched Analysis From the German Aortic Valve RegistryMohamed Abdel-Wahab, Buntaro Fujita, Christian Frerker, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 13, 2012
One-year outcomes of the Surgical Treatment of Aortic Stenosis With a Next Generation Surgical Aortic Valve (TRITON) trial: a prospective multicenter study of rapid-deployment aortic valve replacement with the EDWARDS INTUITY Valve SystemAlfred A Kocher, Günther Laufer, Axel Haverich, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 15, 2014
Three-year hemodynamic performance, left ventricular mass regression, and prosthetic-patient mismatch after rapid deployment aortic valve replacement in 287 patientsAxel Haverich, Thorsten C Wahlers, Michael A Borger, et al.
Interactive Cardiovascular and Thoracic Surgery|December 10, 2021
Results from a multicentre evaluation of plug use for left ventricular assist device explantationEvgenij V Potapov, Nikolaos Politis, Matthias Karck, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 4, 2021
Five-year outcome in 18 010 patients from the German Aortic Valve RegistryFriedhelm Beyersdorf, Timm Bauer, Nick Freemantle, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 20, 2016
Early outcomes after isolated aortic valve replacement with rapid deployment aortic valveThorsten C W Wahlers, Axel Haverich, Michael A Borger, et al.
Circulation|December 21, 2018
Patients at Intermediate Surgical Risk Undergoing Isolated Interventional or Surgical Aortic Valve Implantation for Severe Symptomatic Aortic Valve StenosisNicolas Werner, Ralf Zahn, Andreas Beckmann, et al.
Science Translational Medicine|January 21, 2021
ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinomaPrateek Khanna, Hong Jie Soh, Chun-Hau Chen, et al.
JACC. Advances|February 15, 2025
The Impact of Frailty on VARC-3 Integrated Outcomes in Patients Undergoing Transcatheter Aortic Valve ReplacementDaijiro Tomii, Jonas Lanz, Dik Heg, et al.
Pageof 64